Wendy Mcdermott
Responsable des Ressources Humaines chez LEXICON PHARMACEUTICALS, INC.
Fortune : 81 149 $ au 30/04/2024
Profil
Wendy E.
Mcdermott is currently the Vice President-Human Resources at Lexicon Pharmaceuticals, Inc. She previously worked as the Vice President-Human Resources at Sanofi Corp.
from 2017 to 2019 and as the Chief People Officer at Cornerstone Pharmaceuticals, Inc. She obtained an undergraduate degree from the State University of New York College at Plattsburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2024 | 52 694 ( 0,02% ) | 81 149 $ | 30/04/2024 |
Postes actifs de Wendy Mcdermott
| Sociétés | Poste | Début |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 01/01/2022 |
Anciens postes connus de Wendy Mcdermott
| Sociétés | Poste | Fin |
|---|---|---|
| Sanofi Corp. | Responsable des Ressources Humaines | 01/01/2019 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Responsable des Ressources Humaines | - |
Formation de Wendy Mcdermott
| State University of New York College at Plattsburgh | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
| Sanofi Corp. |
